Pérou - espagnol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

drogueria peru s.a.c. - paracetamol; dextrometorfano bromhidrato; maleato de clorfeniramina; clorhidrato de fenilefrina; - capsula blanda - por capsula; paracetamol 325.000000 mg; bromhidrato de dextrometorfano 10.000000 mg; maleato de clorfeniramina 2.000000 mg; clorhidrato de fenilefrina 5.000000 mg; - clorfeniramina, combinaciones

Pérou - espagnol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

drogueria peru s.a.c. - clorhidrato de idarubicina; - polvo para solucion inyectable - por vial5 mg; clorhidrato de idarubicina 5.000000 mg; - idarubicina

Union européenne - espagnol - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Union européenne - espagnol - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Union européenne - espagnol - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

neuraxpharm spain s.l. - captopril; hidroclorotiazida - comprimido - 50 mg/25 mg - captopril 50 mg; hidroclorotiazida 25 mg - captopril y diuréticos

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

teva pharma s.l.u. - captopril; hidroclorotiazida - comprimido - 50 mg/25 mg - captopril 50 mg; hidroclorotiazida 25 mg - captopril y diuréticos

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sandoz farmaceutica s.a. - captopril; hidroclorotiazida - comprimido - 50 mg/25 mg - captopril 50 mg; hidroclorotiazida 25 mg - captopril y diuréticos

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

pensa pharma, s.a.u - captopril; hidroclorotiazida - comprimido - 50 mg/25 mg - captopril 50 mg; hidroclorotiazida 25 mg - captopril y diuréticos

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorio stada s.l. - ramipril; hidroclorotiazida - comprimido - 2,5 mg/12,5 mg - ramipril 2,5 mg; hidroclorotiazida 12,5 mg - ramipril y diuréticos